Overview
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Status:
Completed
Completed
Trial end date:
2016-03-01
2016-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is a multicenter, prospective, observational study to evaluate the long-term safety of OZURDEX® in patients with macular oedema following central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) or patients with non-infectious posterior segment uveitis in real-world clinical practice.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AllerganTreatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Criteria
Inclusion Criteria:- Macular oedema following either BRVO or CRVO or non-infectious uveitis
- Requires treatment with OZURDEX®
Exclusion Criteria:
- Current participation in any clinical study